Clinical Trial Update: Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating trientine plus pegylated liposomal doxorubicin and carboplatin in epithelial ovarian cancer and peritoneal/ fallopian tube malignanci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Neoplasms Malignant
• Peritoneal Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)
• Trientine (trientine)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Ovarian Neoplasms Malignant (Excl Germ Cell), Peritoneal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-10